In May 2026, Innogen announced it will present full Phase IIb results from its ENLIGHT clinical trial at the 2026 American Diabetes Association (ADA) Scientific Sessions
It's not just that the formula contains fragrance
2 To guide these conversations effectively, providers may benefit from grounding treatment recommendations in a continuum-of-care approach, one that reflects obesity as a chronic condition requiring ongoing, evolving support and acknowledges the potential out-of-pocket costs that can influence follow-through over time
They also looked at collagen and elastin production
Medication handling and safety are essential
[DOI] [PMC free article] [PubMed] [Google Scholar] 105.Sawa T., Ono K., Tsutsuki H., Zhang T., Ida T., Nishida M., Akaike T